SOFI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. SOFI is in a sharp downswing (down 7.7% regular session) with bearish momentum still expanding (negative MACD histogram), and while it is extremely oversold (RSI_6 ~11) and sitting near support (22.22–23.22), there is no proprietary buy signal today. This setup can bounce, but the trend is still down and the next key reclaim level is the pivot near 24.84; until price regains that area, odds favor chop-to-lower rather than a clean reversal. For an impatient buyer, the risk/reward is not attractive enough to call this a buy today.
Trend/momentum: Bearish. MACD histogram at -0.313 and negatively expanding signals downside momentum is still building. RSI_6 at ~11 is deeply oversold, suggesting a short-term snapback is possible, but oversold alone is not a reversal signal. Levels: Current ~22.5 is just above S2 22.22 and below S1 23.221; this is a key support band. Upside resistance levels are 24.841 (pivot) then 26.46 (R1). The moving averages are converging, consistent with a volatile transition phase—but with momentum still negative, the base case is weak until price can reclaim the pivot area. Near-term pattern stats provided: Similar-pattern study implies ~-0.32% over a week and ~-7.49% over a month, aligning with a bearish intermediate trend despite possible short-term mean reversion.
near S2 support (22.
increases odds of a short-term bounce.
Recent analyst actions skew cautious: BofA resumed Underperform with $20.50 target; Goldman cut target to $
Stock is below key pivot/resistance levels; failure to hold ~22.22–23.22 support risks another leg lower.
Latest quarter provided: 2025/Q3. Revenue rose to ~$800.2M (+39.55% YoY). Net income rose to ~$139.4M (+129.47% YoY). EPS increased to $0.11 (+120% YoY). This is a strong growth/profitability acceleration profile in the most recent reported quarter.
Recent trend: Mixed-to-cautious. On 2026-01-06, BofA resumed with Underperform and a $20.50 target (bearish, limited upside thesis tied to valuation/capital raises). Goldman Sachs lowered its target to $24 (kept Neutral). Offsetting this, Barclays raised its target to $28 (Equal Weight), and JPMorgan previously raised to $31 (Neutral), while Truist trimmed to $28 (Hold) citing tougher comps/slowdown. Wall Street pros: Strong recent growth, potential for improved consumer finance/mortgage backdrop in 2026 (Barclays/JPM context). Wall Street cons: Valuation/upside debate, dilution/capital raises creating overhang and acquisition questions, and expectations of growth normalization (BofA/Truist framing).
